Today: 13 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Bitcoin price holds $95,000 as U.S. crypto bill delay and ETF swings keep traders cautious

Bitcoin price holds $95,000 as U.S. crypto bill delay and ETF swings keep traders cautious

Bitcoin rose above $95,000 Saturday after the U.S. Senate Banking Committee postponed debate on a crypto bill, following criticism from Coinbase CEO Brian Armstrong. U.S. spot bitcoin ETFs saw a $395 million outflow Friday after two days of strong inflows, ending the week with a net $1.4 billion gain. Treasury yields climbed, with the 10-year closing near 4.23%. U.S. markets will be closed Monday for Martin Luther King Jr. Day.
17 January 2026
Micron stock set for Tuesday test after $1.8 billion Taiwan fab deal

Micron stock set for Tuesday test after $1.8 billion Taiwan fab deal

Micron Technology signed an exclusive letter of intent to buy Powerchip’s P5 fab in Taiwan for $1.8 billion in cash, aiming to boost DRAM wafer output by late 2027. Shares jumped 7.8% to $362.75 on Friday. A Micron director bought 23,200 shares last week, raising their direct stake to 25,910. U.S. markets will close Monday for Martin Luther King Jr. Day; trading resumes Tuesday.
Silver price slips from record highs — what traders are watching next week

Silver price slips from record highs — what traders are watching next week

Spot silver fell 2.9% to $89.65 an ounce Friday, retreating from a record $93.57 set the previous session. Retail investors poured $921.8 million into silver-backed ETFs over 30 days, crowding the trade. Fed officials signaled no guarantee of rate cuts ahead of the Jan. 27-28 meeting. U.S. markets close Monday for Martin Luther King Jr. Day, limiting liquidity.
RTX stock hits a fresh 52-week high — here’s what to watch before earnings

RTX stock hits a fresh 52-week high — here’s what to watch before earnings

RTX shares rose 1.05% to $201.92 Friday, marking a seventh straight gain and a new 52-week high. Susquehanna raised its price target to $230 ahead of RTX’s Jan. 27 earnings release. Investors are watching for updates on Pratt & Whitney’s geared turbofan engine issues. Defense stocks outperformed the broader market as policy risks and geopolitical tensions persisted.
Global stock markets hover near records — but Fed-cut doubts and earnings could jolt prices

Global stock markets hover near records — but Fed-cut doubts and earnings could jolt prices

Global stocks ended the week near record highs but lost momentum as traders lowered expectations for U.S. rate cuts. The S&P 500 slipped 0.1% to 6,940.01, with the Dow down 0.2% and Nasdaq off 0.1%. Treasury yields rose after Trump signaled he may keep Kevin Hassett as economic adviser. Asian tech markets hit records, led by TSMC earnings and a U.S.-Taiwan trade deal.
IBM stock price jumps on Sovereign Core push as traders eye earnings week ahead

IBM stock price jumps on Sovereign Core push as traders eye earnings week ahead

IBM shares rose 2.6% to $305.67 Friday after unveiling its new Sovereign Core software for regulated AI and cloud workloads. Trading volume reached 6.2 million shares. The company plans a tech preview in February and aims for full release by mid-2026. Investors are also watching IBM’s pending $11 billion Confluent acquisition, with a key shareholder vote set for Feb. 12.
Goldman Sachs stock price cools after earnings pop — here’s what could move GS next week

Goldman Sachs stock price cools after earnings pop — here’s what could move GS next week

Goldman Sachs shares fell 1.4% Friday to $962, trimming gains after a surge on strong quarterly profits and a dividend hike. The bank reported Q4 net earnings of $4.62 billion on $13.45 billion in revenue and raised its dividend to $4.50 per share. Investors are watching for volatility after options expiration and ahead of the Federal Reserve’s Jan. 27-28 meeting. U.S. markets reopen Tuesday after the holiday.
Chevron stock: Venezuela license shift and Leviathan gas bet put CVX back on watch

Chevron stock: Venezuela license shift and Leviathan gas bet put CVX back on watch

Chevron shares edged up 0.1% to $166.26 Friday after U.S. officials said they are moving to expand the company’s Venezuela license, potentially allowing cash payments to Caracas. Oil prices rose, with Brent closing at $64.13 a barrel. Chevron and partners approved a $2.36 billion expansion of Israel’s Leviathan gas field. U.S. markets will be closed Monday for Martin Luther King Jr. Day.
Morgan Stanley stock price slips after earnings pop — what MS investors watch next

Morgan Stanley stock price slips after earnings pop — what MS investors watch next

Morgan Stanley shares fell 1.1% to $189.09 Friday, reversing gains from a post-earnings rally. The drop followed strong quarterly results, with earnings of $2.68 per share and a 47% jump in investment banking revenue. Financial stocks broadly slipped amid concerns over President Trump’s proposed credit-card rate cap. U.S. markets will remain closed Monday for Martin Luther King Jr. Day.
Caterpillar stock price holds near $647 as CAT heads into a holiday-shortened week — here’s what matters next

Caterpillar stock price holds near $647 as CAT heads into a holiday-shortened week — here’s what matters next

Caterpillar shares closed Friday at $646.89, nearly flat, then slipped to $646.50 after hours. U.S. markets will be closed Monday for Martin Luther King Jr. Day. Caterpillar reports fourth-quarter and full-year earnings Jan. 29, with investors watching for signals on demand and dealer inventories. Broader U.S. indexes ended the week lower as earnings season began.
1 282 283 284 285 286 702

Stock Market Today

  • 3 UK Mid-Cap Stocks Offering Growth and Value: Tate & Lyle, Hikma Pharmaceuticals, and The Merchants Trust
    March 13, 2026, 1:06 PM EDT. The Merchants Trust targets above-average income and long-term capital growth by investing in high-yield UK large caps, recently focusing on mid-cap growth stocks. Tate & Lyle (LSE: TATE), a speciality ingredients maker, has restructured its business, selling commoditised units and acquiring speciality firms, leading to a robust but temporarily suppressed earnings outlook due to inflation-driven market challenges, particularly in the US. Hikma Pharmaceuticals (LSE: HIK) produces generic, branded, and speciality drugs with a wide geographic footprint, benefiting from ageing populations and increased generic drug use amid health budget constraints. Both companies present potential opportunities for investors seeking solid growth and undervalued stocks in the UK mid-cap arena.
Go toTop